Bank of New York Mellon »

Sionna Therapeutics shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Sionna Therapeutics (SION) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Sionna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sionna Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sionna Therapeutics by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2025-09-30 $808k 28k 29.41
2025-06-30 $419k 24k 17.35

More positions owned by Bank of New York Mellon

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Inc-class A Cl A (META)
Broadcom (AVGO)
Ishares Core S&p 500 Etf Core (IVV)
Alphabet Cl A (GOOGL)
Alphabet CL C (GOOG)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Berkshire Hathaway Inc-cl B CL B (BRK.B)
Exxon Mobil Corporation (XOM)
Mastercard Inc - A Cl A (MA)
Johnson & Johnson (JNJ)

View all positions for Bank of New York Mellon

Top funds holding Sionna Therapeutics

RA Capital Management
Tpg Gp A
OrbiMed Advisors
Atlas Venture Life Science Advisors
Viking Global Investors
Enavate Sciences GP
Jpmorgan Chase & Co
Perceptive Advisors
Vanguard Group
Jennison Associates
Deerfield Management Company
Standard Life Aberdeen
BlackRock
Soleus Capital Management
Baker Bros. Advisors

View all funds holding Sionna Therapeutics